NASDAQ: VIRVir Biotechnology Inc Stock Ownership - Who owns Vir Biotechnology?
Insider buying vs selling
Have Vir Biotechnology Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Vicki L. Sato | Director | 2026-03-02 | 21,800 | $9.50 | $207.19kSell |
| Vicki L. Sato | Director | 2026-03-02 | 200 | $9.98 | $2.00kSell |
| Mark Eisner | EVP and Chief Medical Officer | 2026-02-25 | 1,889 | $9.82 | $18.55kSell |
| Verneuil Vanina De | EVP General Counsel Corp Sec | 2026-02-25 | 13,700 | $9.82 | $134.53kSell |
| Vicki L. Sato | Director | 2026-02-24 | 200 | $10.26 | $2.05kSell |
| Backer Marianne De | Chief Executive Officer | 2026-02-24 | 14,762 | $9.53 | $140.73kSell |
| Verneuil Vanina De | EVP General Counsel Corp Sec | 2026-02-24 | 3,117 | $9.53 | $29.71kSell |
| Mark Eisner | EVP and Chief Medical Officer | 2026-02-24 | 1,616 | $9.53 | $15.41kSell |
| Jason Obyrne | EVP Chief Financial Officer | 2026-02-24 | 1,634 | $9.53 | $15.58kSell |
| Brent Sabatini | SVP Chief Accounting Officer | 2026-02-24 | 1,430 | $9.53 | $13.63kSell |
VIR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when VIR insiders and whales buy or sell their stock.
VIR Shareholders
What type of owners hold Vir Biotechnology Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Alaska Permanent Fund Corp | 11.95% | 16,666,668 | $151.67M | Insider |
| Blackrock Inc | 11.70% | 16,330,103 | $148.60M | Institution |
| Svf Endurance Cayman Ltd | 9.84% | 13,728,924 | $124.93M | Insider |
| Sb Investment Advisers Uk Ltd | 9.40% | 13,116,977 | $119.36M | Institution |
| Arch Venture Management LLC | 9.26% | 12,916,663 | $117.54M | Institution |
| Vanguard Group Inc | 8.99% | 12,548,944 | $114.20M | Institution |
| Gsk PLC | 6.13% | 8,550,954 | $77.81M | Institution |
| State Street Corp | 4.47% | 6,229,555 | $56.69M | Institution |
| Temasek Holdings Private Ltd | 3.94% | 5,499,999 | $50.05M | Insider |
| Dhabi Investment Authority Abu | 2.63% | 3,666,666 | $33.37M | Insider |
VIR vs Biotech Stocks
Vir Biotechnology Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.